7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Kimberly-Clark Hikes Dividend

by Zacks Equity Research

March 01, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Kimberly-Clark Corporation ( KMB - Analyst Report ) , with its quarterly dividend hike to 74 cents per share from 70 cents per share, boasts of a record of dividend increase for 40 years consecutively.

The company hiked its dividend by 6% and the increased dividend is payable on April 3, 2012 to shareholders of record on March 9, 2012.

The move comes a month after the company posted outstanding fourth quarter and fiscal 2011 earnings of $1.28 and $4.80 per share, which were 7.0% and 2.6% higher than the year-ago earnings. The growth was mainly attributable to sales growth, cost savings and a lower share count. However, these were partially offset by rising input cost inflation, higher effective tax rate and lower net income from equity companies.

Though the company did not repurchase any common stock in the fourth quarter of 2011, Kimberly-Clark‘s total buybacks in fiscal 2011 totaled 19.0 million shares at a cost of $1.24 billion. In addition, share repurchases are expected to total $900 million to $1.1 billion in fiscal 2012, subject to market conditions.

Kimberly-Clark was anticipating this dividend increase although cash provided by operations in the fourth quarter of 2011 amounted to $517 million as compared to $948 million in the prior-year quarter. The decline was driven by increased working capital compared to a significant decrease in the year-ago period, along with higher defined benefit pension plan contributions, partially offset by improved cash earnings.

Cash provided by operations in fiscal 2011 was also lower than 2010 at $2.29 billion, driven by higher pension contributions in 2011.

Capital spending in the fourth quarter of 2011 was $312 million as compared to $353 million in 2010, whereas it amounted to $968 million in fiscal 2011. However, the capital spending in fiscal 2012 is expected to be in line with the company's long-term target of 4.5% to 5.5% of net sales, in the range of $1.0 to $1.1 billion.

Recently, The Coca Cola Company ( KO - Analyst Report ) also hiked its quarterly dividend by 8.5% to 51 cents per share from 47 cents per share. The dividend is payable on April 1, 2012 to shareholders of record on March 15, 2012.

Kimberly-Clark, which competes with Procter & Gamble Co. ( PG - Analyst Report ) , currently holds a Zacks #3 Rank, which translates into a short-term Hold rating. On a long-term basis, we maintain a Neutral rating on the stock.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.